GlassScriptPhysician profile
Matthew David Cummock
NPI 1669869665
$54,907.43
in general payments reported to CMS, 2019-2025
29 companies · $25K in 2025
The $25K reported for 2025 was more than what 91% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $11K · 2023: $12K · 2024: $7,211 · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Food and Beverage: $14K · Travel and Lodging: $10K · Entertainment: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,800.00 |
| Food and Beverage | $14,071.77 |
| Travel and Lodging | $10,331.60 |
| Entertainment | $162.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyocera Medical Technologies, INC. | $18,239.00 | 2023-2025 | |
| Globus Medical, INC. | $10,274.01 | 2022-2025 | Excelsiusgps Robotic Navigation System, Xlif, Anterior Disc Prep |
| Alphatec Spine, INC | $8,010.05 | 2023-2025 | Other - Miscellaneous, Battalion Tlif - PC, Safeop |
| Nuvasive, INC. | $4,800.78 | 2022-2023 | Xlif, Reline, Simplify Cervical Artificial Disc |
| Stryker Corporation | $3,728.41 | 2022-2023 | Serrato, Es2 Spinal System, Tritanium |
| Spineology INC. | $2,539.60 | 2022-2025 | Optimesh Expandable Interbody Fusion System |
| Medtronic, INC. | $2,460.44 | 2022-2025 | Unid_pass, Atlantis Anterior Cervical Plate System, Stealthstation S8 Platform |
| Cerapedics INC. | $580.96 | 2023-2025 | I-Factor Peptide Enhanced Bone Graft |
| Carlsmed, INC. | $532.59 | 2022-2024 | Aprevo |
| Depuy Synthes Sales INC. | $489.35 | 2023-2024 | Viper, Symphony, Spine & Trauma 3d Navigation |
| Ossdsign USA Incorporated | $488.68 | 2024-2025 | Ossdsign Catalyst |
| Baxter Healthcare | $463.58 | 2022 | |
| Xenix Medical LLC | $380.11 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $333.42 | 2022-2023 | Iovera, Exparel |
| Zimvie INC. | $292.05 | 2023-2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Augmedics INC. | $195.54 | 2022-2023 | Xvision |
| Sivantage, INC. | $164.43 | 2025 | |
| Carbofix Spine INC | $150.34 | 2025 | |
| 4web, INC. | $149.84 | 2025 | Spine Truss System |
| Integrity Implants INC. Dba Accelus | $114.99 | 2023 | |
| Ebi, LLC | $109.97 | 2025 | Spf Xl Iib Implantable Spinal Fusion Stimulator |
| Highridge Medical LLC | $109.97 | 2025 | Spf Xl Iib Implantable Spinal Fusion Stimulator |
| Astrazeneca Pharmaceuticals LP | $109.06 | 2023 | Andexxa |
| Integrity Implants INC. | $63.03 | 2022 | |
| Boston Scientific Corporation | $32.63 | 2025 | Intracept |
| Si-Bone, INC. | $29.33 | 2023 | |
| Orthofix Medical, INC. | $22.96 | 2023 | Spinal-Stim, Physio-Stim |
| Abbott Laboratories | $21.44 | 2023 | Proclaim |
| Alafair Biosciences, INC. | $20.87 | 2025 | Versawrap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Cummock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.